Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katya Tsaioun

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Alternatives to Laboratory Animals : ATLA|October 8, 2009
De-risking drug discovery with ADDME -- avoiding drug development mistakes earlyKatya Tsaioun, Mary Jacewicz
BMC Neurology|June 19, 2009
ADDME--Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspectiveKatya Tsaioun, Michel Bottlaender, Aloise Mabondzo, et al.
ALTEX|January 31, 2022
How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessmentSebastian Hoffmann, Paul Whaley, Katya Tsaioun
ALTEX|November 3, 2016
Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methodsKatya Tsaioun, Bas J Blaauboer, Thomas Hartung
Expert Opinion on Drug Metabolism & Toxicology|May 16, 2009
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidatesJudith K Gwathmey, Katya Tsaioun, Roger J Hajjar
Bioorganic & Medicinal Chemistry|April 5, 2011
QSAR-based permeability model for drug-like compoundsRafael Gozalbes, Mary Jacewicz, Robert Annand, et al.
ALTEX|May 22, 2019
Software tools for literature screening in systematic reviews in biomedical researchStevie Van der Mierden, Katya Tsaioun, André Bleich, et al.
Drug Discovery Today|January 27, 2022
Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: A case for ARDS therapy developmentUsamah S Kayyali, Elizabeth Ghandakly, Natesh Singh, et al.
Data in Brief|May 2, 2022
A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptidesShivalika Tanwar, Patrick Auberger, Germain Gillet, et al.
ALTEX|January 16, 2022
Probabilistic risk assessment - the keystone for the future of toxicologyAlexandra Maertens, Emily Golden, Thomas H Luechtefeld, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Alternatives to Laboratory Animals : ATLA|October 8, 2009
De-risking drug discovery with ADDME -- avoiding drug development mistakes earlyKatya Tsaioun, Mary Jacewicz
BMC Neurology|June 19, 2009
ADDME--Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspectiveKatya Tsaioun, Michel Bottlaender, Aloise Mabondzo, et al.
ALTEX|January 31, 2022
How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessmentSebastian Hoffmann, Paul Whaley, Katya Tsaioun
ALTEX|November 3, 2016
Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methodsKatya Tsaioun, Bas J Blaauboer, Thomas Hartung
Expert Opinion on Drug Metabolism & Toxicology|May 16, 2009
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidatesJudith K Gwathmey, Katya Tsaioun, Roger J Hajjar
Bioorganic & Medicinal Chemistry|April 5, 2011
QSAR-based permeability model for drug-like compoundsRafael Gozalbes, Mary Jacewicz, Robert Annand, et al.
ALTEX|May 22, 2019
Software tools for literature screening in systematic reviews in biomedical researchStevie Van der Mierden, Katya Tsaioun, André Bleich, et al.
Drug Discovery Today|January 27, 2022
Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: A case for ARDS therapy developmentUsamah S Kayyali, Elizabeth Ghandakly, Natesh Singh, et al.
Data in Brief|May 2, 2022
A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptidesShivalika Tanwar, Patrick Auberger, Germain Gillet, et al.
ALTEX|January 16, 2022
Probabilistic risk assessment - the keystone for the future of toxicologyAlexandra Maertens, Emily Golden, Thomas H Luechtefeld, et al.
Pageof 4